In AD patients, low efficacy of antioxidant response, possibly involving PGC1α as a regulator and SOD2 as an effector, likely allows the vicious cycle linking Aβ, ROS, and oxidative damage to occur, leading to dementia progression. The gene discussed is PPARGC1A; the disease is Alzheimer disease.